EUVIMEDEUVIMED entdecken
Open Access

One-month postoperative α-blocker therapy reduces morbidity and increases patients’ satisfaction and well-being following water jet aquablation for treating benign prostatic obstruction: a randomized prospective trial

Dolev Perez, Ariel Mamber, Michael Pasherstnik, Dmitry Koulikov, Ala Eddin Natsheh, Ofer Z Shenfeld, Ilan Z Kafka, Adam Hen, Andres Malinger, Avital Zeldin, Israel A Ostrovsky, Boris Chertin

Central European Journal of Urology · 2026 · 79 (2) · 140-146

DOI: 10.5173/ceju.2025.0243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Central European Journal of Urology, 2026. Verfasst von Dolev Perez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shaare Zedek Medical Center, Jerusalem, Israel. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The study aimed to evaluate whether continuing α-blocker therapy for one month after aquablation improves early clinical outcomes in patients undergoing surgery for benign prostatic obstruction (BPO). Material and methods: This prospective, single-center study enrolled 240 consecutive patients with symptomatic BPO who underwent aquablation between 2023 and 2025. Patients were divided into two cohorts: cohort A (n = 120) discontinued BPH medications postoperatively, while cohort B (n = 120) continued α-blocker therapy for one month. Functional, sexual, and safety outcomes were assessed at 3, 6, and 12 months using validated tools (IPSS, QoL, VAS, IIEF, MSHQ-EjD-SF, SF-ICIQ). Statistical analysis was used to compare symptom scores, complication rates, and retreatment frequencies between groups.

Results

Both cohorts experienced significant symptom improvement following aquablation. However, cohort B showed superior early outcomes, including a greater reduction in irritative symptoms (p = 0.014 at 3 months; p = 0.02 at 12 months), lower VAS pain scores, and fewer postoperative complications (22.5% vs 30.8%, p = 0.15), with nonsignificantly lower rates of moderate (Grade II) complications in cohort B. Sexual function remained stable in both groups, with cohort B demonstrating improved ejaculatory function scores at all time points. No increase in adverse events was observed with continued use of α-blockers.

Conclusions

Short-term continuation of α-blocker therapy following aquablation enhances early postoperative recovery, reduces complications, and improves patient-reported well-being without compromising sexual or functional outcomes. Routine one-month α-blocker therapy is a valuable adjunct in aquablation postoperative care.

Schlagwörter

Stichwörter der Autor:innen

aquablationbenign prostatic hyperplasiabladder outlet obstructionα-blocker

Autor:innen und Institutionen

  • Department of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Department of Anesthesiology, Shaare Zedek Medical Center, Jerusalem, Israel.

Zitieren

APA

Perez, D., Mamber, A., Pasherstnik, M., Koulikov, D., Natsheh, A. E., Shenfeld, O. Z., Kafka, I. Z., Hen, A., Malinger, A., Zeldin, A., Ostrovsky, I. A., & Chertin, B. (2026). One-month postoperative α-blocker therapy reduces morbidity and increases patients’ satisfaction and well-being following water jet aquablation for treating benign prostatic obstruction: a randomized prospective trial. Central European Journal of Urology, 79(2), 140-146. https://doi.org/10.5173/ceju.2025.0243

Vancouver

Perez D, Mamber A, Pasherstnik M, Koulikov D, Natsheh AE, Shenfeld OZ, et al. One-month postoperative α-blocker therapy reduces morbidity and increases patients’ satisfaction and well-being following water jet aquablation for treating benign prostatic obstruction: a randomized prospective trial. Central European Journal of Urology. 2026;79(2):140-146. doi:10.5173/ceju.2025.0243

BibTeX
@article{Perez2026,
  author = {Perez, Dolev and Mamber, Ariel and Pasherstnik, Michael and Koulikov, Dmitry and Natsheh, Ala Eddin and Shenfeld, Ofer Z and Kafka, Ilan Z and Hen, Adam and Malinger, Andres and Zeldin, Avital and Ostrovsky, Israel A and Chertin, Boris},
  title = {One-month postoperative α-blocker therapy reduces morbidity and increases patients’ satisfaction and well-being following water jet aquablation for treating benign prostatic obstruction: a randomized prospective trial},
  journal = {Central European Journal of Urology},
  year = {2026},
  volume = {79},
  number = {2},
  pages = {140--146},
  doi = {10.5173/ceju.2025.0243}
}
Kostenlos starten →